Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer

Molecular Carcinogenesis

Volumn 34, Issue 2, 2002, Pages 78-90

  Manderson, Emily N ^a   Presneau, Nadège ^b   Provencher, Diane ^c,d   Mes Masson, Anne Marie ^c,d   Tonin, Patricia N ^a,b,e  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c Institut du Cancer de Montreal   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Chromosome 3; Loss of heterozygosity; Ovarian cancer; Tumor protein p53 (TP53); Tumor suppressor gene

Indexed keywords

PROTEIN P53;

AGING; ARTICLE; AUTOSOME; CANCER GRADING; CANCER STAGING; CHROMOSOME 13; CHROMOSOME 17; CHROMOSOME 3P; CHROMOSOME MARKER; FEMALE; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MUTATION RATE; OVARY CANCER; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; X CHROMOSOME;

EID: 0036277086     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10051     Document Type: Article

References (50)

1. Cytogenetic studies in ovarian cancer
2. Chromosome aberrations in 35 primary ovarian carcinomas
3. Chromosome abnormalities in primary endometrioid ovarian carcinoma
4. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms
5. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas
6. Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/neu gene amplification
7. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas
8. Mapping of chromosome 3p deletions in human epithelial ovarian tumors
9. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer
10. Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22-25
11. Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer
12. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes
13. Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer
14. In vitro growth suppression and morphological change in a human renal cell carcinoma cell line by the introduction of normal chromosome 3 via microcell fusion
15. Suppression of tumorigenicity in three different cell lines of human oral squamous cell carcinoma by introduction of chromosome 3p via microcell-mediated chromosome transfer
16. Nonrandom loss of human chromosome 3 fragments from mouse-human microcell hybrids following progressive growth in SCID mice
17. Differential elimination of 3p and retention of 3q segments in human/ mouse microcell hybrids during tumor growth
18. Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer
19. Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: Correlation to clinicopathological variables
20. Allelic loss in ovarian cancer
21. Potential role of the inactivated X chromosome in ovarian epithelial tumor development
22. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers
23. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer
24. Classification and staging of malignant tumors in the female pelvis
25. Primary cultures of normal and tumoral human ovarian epithelium: A powerful tool for basic molecular studies
26. Polymerase chain reaction detection of a highly polymorphic VNTR segment in intron 1 of the human p53 gene
27. Non-radioactive screening of p53 mutations in human oral cancers detected by single strand conformation polymorphism analysis: Comparison with the protein accumulation
28. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers
29. Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer
30. Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancer
31. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma
32. Whole chromosome 17 loss in ovarian cancer
33. Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors
34. Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas
35. Mutation and overexpression of p53 in earlystage epithelial ovarian cancer
36. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms
37. Genomic deletion and p53 inactivation in cervical carcinoma
38. In search of the tumour-suppressor functions of BRCA1 and BRCA2
39. BRCA1 and cell signaling
40. Role of the tumor suppressor gene Brcal in genetic stability and mammary gland tumor formation
41. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
42. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours
43. A somatic BRCA1 mutation in an ovarian tumour
44. Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: Clinicopathological correlations
45. Mutation, ageing, and ovarian cancer
46. Age contrast in ovarian pathology
47. Ovarian cancer: Age contrasts in incidence, histology, disease stage at diagnosis, and mortality